Cancer Therapy & Intergrative is categorized under Oncologists in Las Vegas, NV and active since 2007.
Cancer Therapy & Intergrative was established in 2007, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Rubina Ali, Office Manager at the company’s single location by writing to 3340 Topaz St # 100, Las Vegas, Nevada NV 89121 or by phoning (702) 363-2020. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cancer Therapy & Intergrative |
| Contact Person: | Rubina Ali, Office Manager |
| Address: | 3340 Topaz St # 100, Las Vegas, Nevada 89121 |
| Phone Number: | (702) 363-2020 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Cancer Therapy & Intergrative was started in 2007 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Rubina Ali, Office Manager for inquiries that concern Cancer Therapy & Intergrative by calling the company number (702) 363-2020, as your correspondence is most welcome. Additionally, the physical location of the single location of Cancer Therapy & Intergrative can be found at the coordinates 36.12897,-115.11411 as well as the street address 3340 Topaz St # 100 in Las Vegas, Nevada 89121.
For its online presence, you may visit Cancer Therapy & Intergrative’s website at and engage with its social media outlets through on Twitter and on Facebook.